ADVM
Price
$2.05
Change
-$0.16 (-7.24%)
Updated
May 14, 04:59 PM (EDT)
Capitalization
46.27M
ATXS
Price
$3.97
Change
+$0.07 (+1.79%)
Updated
May 14, 04:59 PM (EDT)
Capitalization
220.09M
89 days until earnings call
Ad is loading...

ADVM vs ATXS

Header iconADVM vs ATXS Comparison
Open Charts ADVM vs ATXSBanner chart's image
Adverum Biotechnologies
Price$2.05
Change-$0.16 (-7.24%)
Volume$15.04K
Capitalization46.27M
Astria Therapeutics
Price$3.97
Change+$0.07 (+1.79%)
Volume$17.04K
Capitalization220.09M
ADVM vs ATXS Comparison Chart
Loading...
ADVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADVM vs. ATXS commentary
May 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADVM is a Hold and ATXS is a Hold.

Ad is loading...
COMPARISON
Comparison
May 14, 2025
Stock price -- (ADVM: $2.21 vs. ATXS: $3.90)
Brand notoriety: ADVM and ATXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADVM: 312% vs. ATXS: 166%
Market capitalization -- ADVM: $46.27M vs. ATXS: $220.09M
ADVM [@Biotechnology] is valued at $46.27M. ATXS’s [@Biotechnology] market capitalization is $220.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $295.2B to $0. The average market capitalization across the [@Biotechnology] industry is $2.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADVM’s FA Score shows that 1 FA rating(s) are green whileATXS’s FA Score has 0 green FA rating(s).

  • ADVM’s FA Score: 1 green, 4 red.
  • ATXS’s FA Score: 0 green, 5 red.
According to our system of comparison, ADVM is a better buy in the long-term than ATXS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADVM’s TA Score shows that 4 TA indicator(s) are bullish while ATXS’s TA Score has 4 bullish TA indicator(s).

  • ADVM’s TA Score: 4 bullish, 5 bearish.
  • ATXS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ATXS is a better buy in the short-term than ADVM.

Price Growth

ADVM (@Biotechnology) experienced а -31.42% price change this week, while ATXS (@Biotechnology) price change was -10.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.95%. For the same industry, the average monthly price growth was +6.81%, and the average quarterly price growth was -5.99%.

Reported Earning Dates

ADVM is expected to report earnings on Apr 15, 2025.

ATXS is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+0.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATXS($220M) has a higher market cap than ADVM($46.3M). ADVM YTD gains are higher at: -52.570 vs. ATXS (-56.376). ADVM has higher annual earnings (EBITDA): -99.25M vs. ATXS (-111.56M). ATXS has more cash in the bank: 328M vs. ADVM (153M). ATXS has less debt than ADVM: ATXS (5.35M) vs ADVM (73.3M). ADVM has higher revenues than ATXS: ADVM (1M) vs ATXS (0).
ADVMATXSADVM / ATXS
Capitalization46.3M220M21%
EBITDA-99.25M-111.56M89%
Gain YTD-52.570-56.37693%
P/E RatioN/AN/A-
Revenue1M0-
Total Cash153M328M47%
Total Debt73.3M5.35M1,369%
FUNDAMENTALS RATINGS
ADVM vs ATXS: Fundamental Ratings
ADVM
ATXS
OUTLOOK RATING
1..100
420
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
60
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
9465
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ADVM's Valuation (30) in the Biotechnology industry is in the same range as ATXS (60). This means that ADVM’s stock grew similarly to ATXS’s over the last 12 months.

ADVM's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ATXS (100). This means that ADVM’s stock grew similarly to ATXS’s over the last 12 months.

ATXS's SMR Rating (97) in the Biotechnology industry is in the same range as ADVM (98). This means that ATXS’s stock grew similarly to ADVM’s over the last 12 months.

ATXS's Price Growth Rating (65) in the Biotechnology industry is in the same range as ADVM (94). This means that ATXS’s stock grew similarly to ADVM’s over the last 12 months.

ATXS's P/E Growth Rating (100) in the Biotechnology industry is in the same range as ADVM (100). This means that ATXS’s stock grew similarly to ADVM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ADVMATXS
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
68%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 10 days ago
78%
Bullish Trend 15 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ADVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA334.0715.69
+4.93%
Tesla
BTC.X104169.8100001356.851600
+1.32%
Bitcoin cryptocurrency
GME28.390.34
+1.21%
GameStop Corp
AAPL212.932.14
+1.02%
Apple
SPY586.843.85
+0.66%
SPDR® S&P 500® ETF

ADVM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADVM has been loosely correlated with IMNM. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ADVM jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADVM
1D Price
Change %
ADVM100%
-18.27%
IMNM - ADVM
49%
Loosely correlated
-0.38%
TENX - ADVM
48%
Loosely correlated
-0.70%
XENE - ADVM
44%
Loosely correlated
-17.43%
CCCC - ADVM
44%
Loosely correlated
-5.06%
ATXS - ADVM
43%
Loosely correlated
-10.76%
More

ATXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATXS has been loosely correlated with KYMR. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ATXS jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATXS
1D Price
Change %
ATXS100%
-10.76%
KYMR - ATXS
56%
Loosely correlated
-3.20%
TRDA - ATXS
54%
Loosely correlated
-1.36%
APGE - ATXS
53%
Loosely correlated
+0.40%
DNLI - ATXS
53%
Loosely correlated
-3.65%
CRNX - ATXS
52%
Loosely correlated
-7.11%
More